Skip to main content
Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · IEX Real-Time Price · USD
0.946
-0.004 (-0.46%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Rapid Micro Biosystems Revenue

In the year 2023, Rapid Micro Biosystems had annual revenue of $22.52M with 31.44% growth. Revenue in the quarter ending December 31, 2023 was $6.34M with 44.88% year-over-year growth.

Revenue (ttm)
$22.52M
Revenue Growth
+31.44%
P/S Ratio
1.80
Revenue / Employee
$116,679
Employees
193
Market Cap
40.47M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.52M5.39M31.44%
Dec 31, 202217.13M-6.10M-26.25%
Dec 31, 202123.23M7.16M44.50%
Dec 31, 202016.08M-435.00K-2.63%
Dec 31, 201916.51M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Oncology Network 1.28B
Cutera 230.18M
ReWalk Robotics 13.85M
Aspira Women's Health 9.15M
Bolt Biotherapeutics 7.88M
Renalytix 2.41M
Revenue Rankings

RPID News

More News